-
7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
-
ChemBase ID:
44462
-
Molecular Formular:
C21H25ClFN3O4
-
Molecular Mass:
437.8923032
-
Monoisotopic Mass:
437.1517622
-
SMILES and InChIs
SMILES:
n1(c2c(c(=O)c(c1)C(=O)O)cc(c(N1C[C@H]3[C@@H](C1)NCCC3)c2OC)F)C1CC1.Cl
Canonical SMILES:
COc1c(N2C[C@@H]3[C@H](C2)CCCN3)c(F)cc2c1n(cc(c2=O)C(=O)O)C1CC1.Cl
InChI:
InChI=1S/C21H24FN3O4.ClH/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H/t11-,16+;/m0./s1
InChIKey:
IDIIJJHBXUESQI-DFIJPDEKSA-N
-
Cite this record
CBID:44462 http://www.chembase.cn/molecule-44462.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
|
|
|
IUPAC Traditional name
|
moxifloxacin hydrochloride
|
|
|
Synonyms
|
Moxifloxacin hydrochloride
|
1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
|
Moxifloxacin hydrochloride
|
Avelox
|
Avalox
|
|
|
CAS Number
|
|
MDL Number
|
|
Beilstein Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
5.6861296
|
H Acceptors
|
7
|
H Donor
|
2
|
LogD (pH = 5.5)
|
-0.79074246
|
LogD (pH = 7.4)
|
-0.4932184
|
Log P
|
-0.49897495
|
Molar Refractivity
|
106.224 cm3
|
Polarizability
|
39.591274 Å3
|
Polar Surface Area
|
82.11 Å2
|
Rotatable Bonds
|
4
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Selleck Chemicals
Sigma Aldrich
Selleck Chemicals -
S1465
|
Research Area: Infection Biological Activity: Moxifloxacin(Avelox, Avalox) is a fourth generation synthetic fluoroquinolone antibacterial agent. Moxifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria. It functions by inhibiting DNA gyrase, a type II topoisomerase and topoisomerase IV, which is an enzyme necessary to separate bacterial DNA, thereby inhibiting cell replication. [1] |
PATENTS
PATENTS
PubChem Patent
Google Patent